Cover Image

Letter to the editor: Safety and immunogenicity of a novel recombinant rabies vaccine

Saved in:

Bibliographic Details
Main Authors:	Anurag Agarwal (Author), Surendra Bahadur Mathur (Author)
Format:	Book
Published:	Taylor & Francis Group, 2022-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Safety and Immunogenicity of a novel three-dose recombinant nanoparticle rabies G protein vaccine administered as simulated post exposure immunization: A randomized, comparator controlled, multicenter, phase III clinical study
by: Ravish H S, et al.
Published: (2021)

Reply to letter to editor by Hadigal et al. regarding the immunogenicity and safety trial of high-dose influenza vaccine in adults aged ≥60 years
by: J. Kevin Yin, et al.
Published: (2022)

Immunogenicity and safety of WHO-approved TRC-ID regimen with a chromatographically purified Vero cell rabies vaccine with or without rabies immunoglobulin in children
by: Piyada Angsuwatcharakon, et al.
Published: (2018)

A recombinant rabies virus chimera expressing the DC-targeting molecular MAB2560 shows enhanced vaccine immunogenicity through activation of dendritic cells.
by: Zhiyuan Gong, et al.
Published: (2023)

A recombinant rabies virus chimera expressing the DC-targeting molecular MAB2560 shows enhanced vaccine immunogenicity through activation of dendritic cells
by: Zhiyuan Gong, et al.
Published: (2023)

The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience
by: Caroline Van Den Ende, et al.
Published: (2017)

Safety and immunogenicity of freeze-dried human rabies vaccines: A phase 3 clinical trial of Zagreb and Essen regimes
by: Jia Li, et al.
Published: (2024)

Letter to the editor concerning the article 'Safety of vaccines administration in hereditary fructose intolerance'
by: Rebeca Saborido-Fiaño, et al.
Published: (2021)

Safety and immunogenicity of a combined Tetanus, Diphtheria, recombinant acellular Pertussis vaccine (TdaP) in healthy Thai adults
by: Chukiat Sirivichayakul, et al.
Published: (2017)

Immunogenicity and safety of live attenuated and recombinant/inactivated varicella zoster vaccines in people living with HIV: A systematic review
by: Valentina Carta, et al.
Published: (2024)

Novel recombinant DNA vaccine candidates for human respiratory syncytial virus: Preclinical evaluation of immunogenicity and protection efficiency
by: Mohamed A. Farrag, et al.
Published: (2017)

Novel vaccines to human rabies.
by: Hildegund C J Ertl
Published: (2009)

Immunogenicity, safety, and tolerability of a recombinant hepatitis B vaccine manufactured by a modified process in healthy young Japanese adults
by: Hiroyuki Kishino, et al.
Published: (2018)

Safety and immunogenicity of a recombinant Staphylococcus aureus α-toxoid and a recombinant Panton-Valentine leukocidin subunit, in healthy adults
by: Michael L. Landrum, et al.
Published: (2017)

Safety and immunogenicity of a novel quadrivalent subunit influenza vaccine in animal models
by: Huayue Ye, et al.
Published: (2020)

Safety and immunogenicity of rabies vaccine as 4 - dose Essen Intramuscular regimen for post exposure prophylaxis: A non - randomized, comparative controlled study
by: Ravish S. Haradanahalli, et al.
Published: (2021)

Immunogenicity of Recombinant Lipid-Based Nanoparticle Vaccines: Danger Signal vs. Helping Hand
by: Vladimir Temchura, et al.
Published: (2023)

Contraindications of COVID-19 Vaccines: A Letter to Editor
by: Javad Ghaffari
Published: (2023)

Immunogenicity and safety of concomitant administration of recombinant COVID-19 vaccine and quadrivalent inactivated influenza vaccine in Chinese adults: An open-label, randomized, controlled trial
by: Tao Huang, et al.
Published: (2024)

A review of safety and immunogenicity of a novel measles, mumps, rubella (MMR) vaccine
by: Nitin Shah, et al.
Published: (2024)

Safety and immunogenicity of the third (booster) dose of inactivated and recombinant protein SARS-CoV-2 vaccine for patients with endocrine-related cancer
by: Shanshan Han, et al.
Published: (2023)

Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: results of a Phase I randomized clinical trial in flavivirus-naïve adults
by: Susan B. Manoff, et al.
Published: (2019)

Letter to the editor: Correspondence on Chinese medical personnel vaccinations
by: Sejal C. Sekhar, et al.
Published: (2022)

Letter to the editor: female sex workers and HPV vaccine
by: Maarten F. Schim van der Loeff, et al.
Published: (2020)

Letter to the editor: female sex workers and HPV vaccine
by: Brandon Brown, et al.
Published: (2020)

A recombinant rabies vaccine that prevents viral shedding in rabid common vampire bats (Desmodus rotundus).
by: Elsa M Cárdenas-Canales, et al.
Published: (2022)

Safety and immunogenicity of a meningococcal B recombinant vaccine when administered with routine vaccines to healthy infants in Taiwan: A phase 3, open-label, randomized study
by: Nan-Chang Chiu, et al.
Published: (2018)

Letter to the Editor
by: Shashendra Aponso, MD, et al.
Published: (2022)

Letter to the Editor
by: Theodorakos Ilias, et al.
Published: (2022)

Letter to the editor
by: Sagrika Shukla, et al.
Published: (2023)

Letters to the Editor
Published: (1996)

Letter to Editor
by: Ayesha Aslam, et al.
Published: (2020)

Letter to the Editor
by: Mohandas Bhat
Published: (2013)

Letter to Editor
by: Zbys Fedorowicz
Published: (2008)

Letter to the Editor
by: Pål Wölner-Hanssen
Published: (1996)

Letters to the Editor
by: Elliott M. Levine
Published: (2001)

Letter to the Editor
by: Manvin S. Amstey
Published: (2000)

Letter to the Editor
by: Walter Chaim
Published: (2000)

Letter to the Editor
by: Gilbert G.G. Donders
Published: (1999)

Letter to the Editor
by: Ricardo Achenbach
Published: (2011)